Outside of its pain-relieving outcomes, conolidine has shown a favorable security margin in preclinical toxicology assessments. As opposed to opioids, which often trigger respiratory melancholy at higher doses, conolidine hasn't made indications of important respiratory suppression. Additionally, behavioral assessments in murine designs recommend a